Marianne Dicander Alexandersson

Président chez OCCLUTECH HOLDING AG Fortune : 792 787 $ au 31/05/2026

Profil

Marianne Dicander Alexandersson is the founder of MDA Management AB. She currently holds several positions, including Chairman at Occlutech Holding AG, Chairman at Sahlgrenska Science Park AB, Director at Oblique Therapeutics AB, Independent Director at Linc AB, Council Member at Försäkringsaktiebolaget Skandia, and Member at Dental & Pharmaceutical Benefits Agency and International Women's Forum Sweden.
In the past, Ms. Dicander Alexandersson served as the Chief Executive Officer of Sjätte AP-fonden from 2011 to 2012, Deputy Chief Executive Officer of Apoteket AB from 2007 to 2010, and Chief Executive Officer of Kronans Droghandel Apotek AB. She also held the position of Chief Executive Officer at GHP Specialty Care AB from 2012 to 2013.
Additionally, she has served as Chairman of the Royal Swedish Academy of Engineering Sciences and Global Health Partner Swe AB. Ms. Dicander Alexandersson was an Independent Director at Castellum AB from 2005 to 2015 and a Director at Svenskt Näringsliv.
She also served as a Director at Mölnlycke Health Care Group AB from 2010 to 2015, Recipharm AB in 2014, Praktikertjänst AB, and Chalmers University of Technology.
From 2015 to 2020, she was an Independent Director at Camurus AB and served as an Independent Director at Promore Pharma AB from 2017 to 2022.
Ms. Dicander Alexandersson was also a Director at Mölnlycke Health Care AB, Mölnlycke AB, and Mölnlycke Holding AB. She served as an Independent Director at Enzymatica AB from 2014 to 2021 and as a Director at West Atlantic AB from 2015 to 2016.
Additionally, she held director positions at Bariatric & Diabetes Center Ajman AB, AdderaCare AB, Apoteksakademin i Sverige AB, Easy Lighting Scandinavia AB, MHC Sweden AB, Xperentia AB, Volvo AB, and Pharmacia AB. Ms. Dicander Alexandersson graduated from Chalmers University of Technology in 1983.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
LINC AB 0,17%	31/12/2025	100 000 ( 0,17% )	792 787 $	31/05/2026

Postes actifs de Marianne Dicander Alexandersson

Sociétés	Poste	Début
OCCLUTECH HOLDING AG	Président	18/06/2021
LINC AB	Directeur/Membre du Conseil	01/01/2020
International Women's Forum Sweden	Corporate Officer/Principal	-
Dental & Pharmaceutical Benefits Agency	Corporate Officer/Principal	-
Försäkringsaktiebolaget Skandia	Corporate Officer/Principal	01/05/2015
Sahlgrenska Science Park AB	Président	-
MDA Management AB	Fondateur	-
Oblique Therapeutics AB	Directeur/Membre du Conseil	-

Anciens postes connus de Marianne Dicander Alexandersson

Sociétés	Poste	Fin
ENZYMATICA AB	Directeur/Membre du Conseil	05/05/2021
░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░